RN7SL541P

Across TCGA pan-cancer cohorts, RN7SL541P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RN7SL541P data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RN7SL541P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL541P expression acts as an unfavorable survival marker, although some lineages such as KIRC and READ show a favorable association.

LUAD, KIRC, and MESO are the cancer types where RN7SL541P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	II,III,IV	0.448	0.618	<.001	128	view →
KIRC	OS	Median	All	0.901	0.845	.006	74	view →
MESO	DFS	Tertile	All	0.202	0.414	.011	45	view →
LUSC	OS	Tertile	All	0.278	0.432	.002	36	view →
LGG	DFS	Tertile	All	0.541	0.749	<.001	36	view →
READ	OS	Median	All	0.851	0.434	.001	26	view →
BRCA	DFS	Tertile	III,IV	0.931	0.849	.016	23	view →
ACC	OS	Tertile	IV	0.327	0.633	.045	18	view →
LIHC	OS	Quartile	All	0.665	0.807	.012	15	view →
ESCA	OS	Median	All	0.659	1.000	.020	11	view →
THCA	DFS	Tertile	IV	0.456	0.825	.049	9	view →
CHOL	OS	Tertile	All	0.775	0.412	.040	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RN7SL541P–LUAD (DFS)

Open the LUAD breakdown →